Company / Assets per Share
Zenas BioPharma, Inc. Assets per Share History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$9.18
FY2025
5-year range
$9.18 / $234.62
FY2023-FY2025
Trend
-96.1%
vs FY2024
Sector context
#104 of 210
Health Care
What the data says
At $9.18, Zenas BioPharma, Inc.'s assets per share ranks #104 of 210 in the Health Care sector. Declined from $44.53 to $9.18 over the past 2 years.
Based on SEC 10-K filings.
9.18 in FY2025.
Declined from $44.53 to $9.18 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#104 of 210 in Health CareTop 50% of 210This company $9.18 Sector average $353.15
▼
-97.4% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 96.1% year-over-year.
- Ranks #104 out of 210 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $9.18 | -96.1% |
| FY2024 | $234.62 | +426.9% |
| FY2023 | $44.53 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026